glp 1 agonist cardiovascular outcomes Glucagon-like peptide receptor agonists: benefits and mechanisms of action BJD

The averages in clinical trials run by the drugs manufacturer were: Wegovy (injection): 15% weight loss in 68 weeks Wegovy (pill): 14% weight loss in 64 weeks Ozempic: 7% weight loss in 30 weeks Rybelsus: 4% weight loss in 6 months These statistics are from clinical trials, where the research team controls many of the variables

Mice deficient in endothelial NO synthase (eNOS), the key enzyme for NO production in vessels, are characterized by faster erythrocyte clearance, possibly due to enhanced erythrocyte PS exposure and subsequent phagocytosis [170]

Phosphoglycerate mutase 5 initiates inflammation in acute kidney injury by triggering mitochondrial DNA release by dephosphorylating the pro-apoptotic protein Bax

Galasko D

As exendin-4 is more resistant to DPP-4-induced degradation, this mechanism is not activated by exendin-4

GSH has limited permeability through the blood-brain barrier(Haddad et al., 2021), a systemic isolation which might contribute to the stability of cerebral GSH levels with pathology(Haddad et al., 2021) and aging(Gong et al., 2022